Global Point-of-Care (POC) Coagulation Testing Market Trend and Development Strategy Analysis 2023-2029

Report ID: ARS11469 | Category: Healthcare | Pages: 122 | Format: PDF | Published Date: December 18,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$2950.00 Multi User-$5500.00

Report Description
View Table of Contents

Report Summary

Market Analysis and Insights: Global Point-of-Care (POC) Coagulation Testing Market
The global Point-of-Care (POC) Coagulation Testing market size in 2022 is 1424.9 million US dollars, and it is expected to be 1953.4 million US dollars by 2029, with a compound annual growth rate of 4.61% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Point-of-Care (POC) Coagulation Testing market include Abbott (U.S.), Danaher (U.S.), Siemens (Germany), Sysmex Corporation (U.S.), and Thermo Fisher Scientific Inc.  (U.S.). The share of the top 3 players in the Point-of-Care (POC) Coagulation Testing market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Point-of-Care (POC) Coagulation Testing market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Optical Technology accounted for XX% of Point-of-Care (POC) Coagulation Testing market in 2022. Mechanical Technology share of XX%.
Hospitals accounted for XX% of the Point-of-Care (POC) Coagulation Testing market in 2022. Clinics accounts for XX%.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Point-of-Care (POC) Coagulation Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Point-of-Care (POC) Coagulation Testing market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Point-of-Care (POC) Coagulation Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Point-of-Care (POC) Coagulation Testing market.

Global Point-of-Care (POC) Coagulation Testing Scope and Market Size
Point-of-Care (POC) Coagulation Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Point-of-Care (POC) Coagulation Testing market will be able to gain the upper hand as they use the report as a powerful resource.

The impact of the outbreak of COVID-19 and the Russia-Ukraine War on the Point-of-Care (POC) Coagulation Testing industry is considered in the report, covering the dynamic analysis of the development of the Point-of-Care (POC) Coagulation Testing industry, including trends, technologies, opportunities, constraints. To ensure report buyers are able to gain in-depth knowledge of the market.

Chapter Outline
   Chapter 1: Introduces the product overview, market scope, economic analysis of global regions, and industry dynamic analysis, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
   Chapters 2-4: Segmented the global Point-of-Care (POC) Coagulation Testing market by type, application and region. Analyze the revenue of market segments from different perspectives.
   Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Point-of-Care (POC) Coagulation Testing market country revenue data, and includes PEST Analysis.
   Chapter 10: Analysis of the competitive environment of Point-of-Care (POC) Coagulation Testing market participants. This mainly includes the revenue and market share of the top players, along with the players' M&A and new entrants and expansion plans.
   Chapter 11: Analyzes the main companies in the Point-of-Care (POC) Coagulation Testing industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
   Chapters 12-14: Provide detailed Point-of-Care (POC) Coagulation Testing market forecast data, broken down by type, application,  and region to help understand future growth trends.
   Chapter 15: Concludes with an explanation of the data sources and research methods. 

Highlights-Regions

North America
   United States
   Canada
Europe
   Germany
   France
   UK
   Italy
   Russia
   Spain
   Nordic
Asia Pacific
   China
   Japan
   South Korea
   India
   Southeast Asia
   Australia
Latin America
   Brazil
   Mexico
   Argentina
Middle East & Africa
   Egypt
   South Africa
   UAE
   Turkey
   Saudi Arabia

Player list
	   Abbott (U.S.)
	   Danaher (U.S.)
	   Siemens (Germany)
	   Sysmex Corporation (U.S.)
	   Thermo Fisher Scientific Inc.  (U.S.)
	   Horiba Ltd.  (Japan)
	   Nihon Kohden Corporation (Japan)
	   F. Hoffmann-La Roche Ltd (Switzerland)
	   Maccura Biotechnology Co. Ltd. (China)
	   Bio Group Medical System (Italy)
	   Genrui Biotech Co. Ltd. (China)
	   A&T Corporation (Japan)
	   Beijing Succeeder Technology Inc. (China)
	   Diagnostica Stago SAS (France)
	   Helena Laboratories Corporation (U.S.)
	   Hycel (Austria)

Types list
   	Optical Technology
   	Mechanical Technology
   	Electrochemical Technology

Application list
   Hospitals
   Clinics
   Home care

Table of Content

1 Point-of-Care (POC) Coagulation Testing Market Introduction and Overview
1.1 Point-of-Care (POC) Coagulation Testing Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Point-of-Care (POC) Coagulation Testing Industry Dynamic Analysis
1.5.1 Point-of-Care (POC) Coagulation Testing Market Trends Analysis
1.5.2 Point-of-Care (POC) Coagulation Testing Market Drivers Analysis
1.5.3 Point-of-Care (POC) Coagulation Testing Market Challenges Analysis
1.5.4 Point-of-Care (POC) Coagulation Testing Market Restraints Analysis
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
1.8 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Point-of-Care (POC) Coagulation Testing Market Insights by Type
2.1 Market Size Insights by Types
2.2 Global Point-of-Care (POC) Coagulation Testing Revenue and Share by Type
3 Global Point-of-Care (POC) Coagulation Testing Market Insights by Application
3.1 Market Size Insights by Application
3.2 Global Point-of-Care (POC) Coagulation Testing Revenue and Share by Application (2018-2023)
4 Global Market Growth Insights
4.1 Global Point-of-Care (POC) Coagulation Testing Market Size (2018-2023)
4.2 Point-of-Care (POC) Coagulation Testing Growth Insights by Regions
4.2.1 Point-of-Care (POC) Coagulation Testing Market Size by Regions: 2018 VS 2023 VS 2029
4.2.2 Point-of-Care (POC) Coagulation Testing Revenue Market Size by Regions (2018-2023)
4.2.3 North America Point-of-Care (POC) Coagulation Testing Market Size (2018-2023)
4.2.4 Europe Point-of-Care (POC) Coagulation Testing Market Size (2018-2023)
4.2.5 Asia-Pacific Point-of-Care (POC) Coagulation Testing Market Size (2018-2023)
4.2.6 Latin America Point-of-Care (POC) Coagulation Testing Market Size (2018-2023)
4.2.7 Middle East & Africa Point-of-Care (POC) Coagulation Testing Market Size (2018-2023)
5 North America
5.1 North America Point-of-Care (POC) Coagulation Testing Revenue by Countries
5.1.1 North America Point-of-Care (POC) Coagulation Testing Revenue by Countries (2018-2023)
5.2 North America PEST Analysis
5.3 United States
5.4 Canada
6 Asia Pacific
6.1 Asia Pacific Point-of-Care (POC) Coagulation Testing Revenue by Countries
6.1.1 Asia Pacific Point-of-Care (POC) Coagulation Testing Revenue by Countries (2018-2023)
6.2 Asia-Pacific PEST Analysis
6.3 China
6.4 Japan
6.5 Korea
6.6 Southeast Asia
6.7 India
6.8 Australia
7 Europe
7.1 Europe Point-of-Care (POC) Coagulation Testing Revenue by Countries
7.1.1 Europe Point-of-Care (POC) Coagulation Testing Revenue by Countries (2018-2023)
7.2 Europe PEST Analysis
7.3 Germany
7.4 France
7.5 UK
7.6 Italy
7.7 Russia
7.8 Spain
7.9 Nordic
8 Latin America
8.1 Latin America Point-of-Care (POC) Coagulation Testing Revenue by Countries
8.1.1 Latin America Point-of-Care (POC) Coagulation Testing Revenue by Countries (2018-2023)
8.2 Latin America PEST Analysis
8.3 Brazil
8.4 Argentina
8.5 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Point-of-Care (POC) Coagulation Testing Revenue by Countries
9.1.1 Middle East & Africa Point-of-Care (POC) Coagulation Testing Revenue by Countries (2018-2023)
9.2 Middle East & Africa PEST Analysis
9.3 Egypt
9.4 South Africa
9.5 UAE
9.6 Turkey
9.7 Saudi Arabia
10 Global Point-of-Care (POC) Coagulation Testing Market Competition, by Players
10.1 Global Point-of-Care (POC) Coagulation Testing Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Point-of-Care (POC) Coagulation Testing Players Market Share in 2022
10.2.2 Top 6 Point-of-Care (POC) Coagulation Testing Players Market Share in 2022
10.2.3 Market Competition Trend
10.3 Point-of-Care (POC) Coagulation Testing Players Head Office, Business Provided
10.4 Point-of-Care (POC) Coagulation Testing Mergers & Acquisitions
10.5 Point-of-Care (POC) Coagulation Testing New Entrants and Expansion Plans
11 Players Profiles
11.1  Abbott (U.S.)
11.1.1 Abbott (U.S.) Company Profile
11.1.2 Point-of-Care (POC) Coagulation Testing Product Overview
11.1.3 Abbott (U.S.) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
11.1.4 Abbott (U.S.) Business Overview
11.1.5 Recent Developments and Plans
11.2  Danaher (U.S.)
11.2.1 Danaher (U.S.) Company Profile
11.2.2 Point-of-Care (POC) Coagulation Testing Product Overview
11.2.3 Danaher (U.S.) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
11.2.4 Danaher (U.S.) Business Overview
11.2.5 Recent Developments and Plans
11.3  Siemens (Germany)
11.3.1 Siemens (Germany) Company Profile
11.3.2 Point-of-Care (POC) Coagulation Testing Product Overview
11.3.3 Siemens (Germany) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
11.3.4 Siemens (Germany) Business Overview
11.3.5 Recent Developments and Plans
11.4  Sysmex Corporation (U.S.)
11.4.1 Sysmex Corporation (U.S.) Company Profile
11.4.2 Point-of-Care (POC) Coagulation Testing Product Overview
11.4.3 Sysmex Corporation (U.S.) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
11.4.4 Sysmex Corporation (U.S.) Business Overview
11.4.5 Recent Developments and Plans
11.5  Thermo Fisher Scientific Inc.  (U.S.)
11.5.1 Thermo Fisher Scientific Inc.  (U.S.) Company Profile
11.5.2 Point-of-Care (POC) Coagulation Testing Product Overview
11.5.3 Thermo Fisher Scientific Inc.  (U.S.) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
11.5.4 Thermo Fisher Scientific Inc.  (U.S.) Business Overview
11.5.5 Recent Developments and Plans
11.6  Horiba Ltd.  (Japan)
11.6.1 Horiba Ltd.  (Japan) Company Profile
11.6.2 Point-of-Care (POC) Coagulation Testing Product Overview
11.6.3 Horiba Ltd.  (Japan) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
11.6.4 Horiba Ltd.  (Japan) Business Overview
11.6.5 Recent Developments and Plans
11.7  Nihon Kohden Corporation (Japan)
11.7.1 Nihon Kohden Corporation (Japan) Company Profile
11.7.2 Point-of-Care (POC) Coagulation Testing Product Overview
11.7.3 Nihon Kohden Corporation (Japan) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
11.7.4 Nihon Kohden Corporation (Japan) Business Overview
11.7.5 Recent Developments and Plans
11.8  F. Hoffmann-La Roche Ltd (Switzerland)
11.8.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Profile
11.8.2 Point-of-Care (POC) Coagulation Testing Product Overview
11.8.3 F. Hoffmann-La Roche Ltd (Switzerland) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
11.8.4 F. Hoffmann-La Roche Ltd (Switzerland) Business Overview
11.8.5 Recent Developments and Plans
11.9  Maccura Biotechnology Co. Ltd. (China)
11.9.1 Maccura Biotechnology Co. Ltd. (China) Company Profile
11.9.2 Point-of-Care (POC) Coagulation Testing Product Overview
11.9.3 Maccura Biotechnology Co. Ltd. (China) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
11.9.4 Maccura Biotechnology Co. Ltd. (China) Business Overview
11.9.5 Recent Developments and Plans
11.10  Bio Group Medical System (Italy)
11.10.1 Bio Group Medical System (Italy) Company Profile
11.10.2 Point-of-Care (POC) Coagulation Testing Product Overview
11.10.3 Bio Group Medical System (Italy) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
11.10.4 Bio Group Medical System (Italy) Business Overview
11.10.5 Recent Developments and Plans
11.11  Genrui Biotech Co. Ltd. (China)
11.11.1 Genrui Biotech Co. Ltd. (China) Company Profile
11.11.2 Point-of-Care (POC) Coagulation Testing Product Overview
11.11.3 Genrui Biotech Co. Ltd. (China) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
11.11.4 Genrui Biotech Co. Ltd. (China) Business Overview
11.11.5 Recent Developments and Plans
11.12  A&T Corporation (Japan)
11.12.1 A&T Corporation (Japan) Company Profile
11.12.2 Point-of-Care (POC) Coagulation Testing Product Overview
11.12.3 A&T Corporation (Japan) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
11.12.4 A&T Corporation (Japan) Business Overview
11.12.5 Recent Developments and Plans
11.13  Beijing Succeeder Technology Inc. (China)
11.13.1 Beijing Succeeder Technology Inc. (China) Company Profile
11.13.2 Point-of-Care (POC) Coagulation Testing Product Overview
11.13.3 Beijing Succeeder Technology Inc. (China) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
11.13.4 Beijing Succeeder Technology Inc. (China) Business Overview
11.13.5 Recent Developments and Plans
11.14  Diagnostica Stago SAS (France)
11.14.1 Diagnostica Stago SAS (France) Company Profile
11.14.2 Point-of-Care (POC) Coagulation Testing Product Overview
11.14.3 Diagnostica Stago SAS (France) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
11.14.4 Diagnostica Stago SAS (France) Business Overview
11.14.5 Recent Developments and Plans
11.15  Helena Laboratories Corporation (U.S.)
11.15.1 Helena Laboratories Corporation (U.S.) Company Profile
11.15.2 Point-of-Care (POC) Coagulation Testing Product Overview
11.15.3 Helena Laboratories Corporation (U.S.) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
11.15.4 Helena Laboratories Corporation (U.S.) Business Overview
11.15.5 Recent Developments and Plans
11.16  Hycel (Austria)
11.16.1 Hycel (Austria) Company Profile
11.16.2 Point-of-Care (POC) Coagulation Testing Product Overview
11.16.3 Hycel (Austria) Point-of-Care (POC) Coagulation Testing Market Performance (2018-2023)
11.16.4 Hycel (Austria) Business Overview
11.16.5 Recent Developments and Plans
12 Global Point-of-Care (POC) Coagulation Testing Forecast Market Insights by Type
12.1 Global Point-of-Care (POC) Coagulation Testing Revenue Market Forecast by Type (2023-2029)
13 Global Point-of-Care (POC) Coagulation Testing Forecast Market Insights by Application
13.1 Point-of-Care (POC) Coagulation Testing Revenue Market Forecast by Application (2023-2029)
14 Global Market Growth Forecast Insights
14.1 Global Point-of-Care (POC) Coagulation Testing Forecast Market Size (2023-2029)
14.2 Point-of-Care (POC) Coagulation Testing Growth Forecast Insights by Regions
14.2.1 Point-of-Care (POC) Coagulation Testing Revenue Forecast Market Size by Regions (2023-2029)
14.2.2 North America Point-of-Care (POC) Coagulation Testing Forecast Market Size (2023-2029)
14.2.3 Europe Point-of-Care (POC) Coagulation Testing Forecast Market Size (2023-2029)
14.2.4 Asia-Pacific Point-of-Care (POC) Coagulation Testing Forecast Market Size (2023-2029)
14.2.5 Latin America Point-of-Care (POC) Coagulation Testing Forecast Market Size (2023-2029)
14.2.6 Middle East & Africa Point-of-Care (POC) Coagulation Testing Forecast Market Size (2023-2029)
15 Methodology and Data Source
15.1 A Methodology
15.1.1 Research Process
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 B Data Source
15.2.1 Legal Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Point-of-Care (POC) Coagulation Testing Market Trend and Development Strategy Analysis 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?